David Drutz, Executive Chairman and CMO, Director at DARA Biosciences, holds 29.79K shares in Altimmune (Ticker: ALT), holds 0.00 shares in DARA Biosciences (Ticker: DARA). Most recently, David Drutz Bought ― shares of Altimmune on Aug 15, 2023 for an estimated value of 861.00.